Evaluating study drug ARGX-117 in Adults With Multifocal Motor Neuropathy

Recruiting
18 years - 99 years
All
3 participants needed
1 Location

Brief description of study

The main goal of this study is to look at the safety and effect of a drug called ARGX-117 in people with multifocal motor neuropathy (MMN). Other goals of the study are to collect information about: • How well different doses of ARGX-117 work • How your body removes ARGX-117 over time (known as “pharmacokinetics”) • What ARGX-117 does to your body (known as “pharmacodynamics”) • How your immune system reacts to ARGX-117 • The impact of ARGX-117 on certain biomarkers and proteins

Detailed description of study

The main goal of this study is to look at the safety and effect of a drug called ARGX-117 in people with multifocal motor neuropathy (MMN). Other goals of the study are to collect information about: • How well different doses of ARGX-117 work • How your body removes ARGX-117 over time (known as “pharmacokinetics”) • What ARGX-117 does to your body (known as “pharmacodynamics”) • How your immune system reacts to ARGX-117 • The impact of ARGX-117 on certain biomarkers and proteins

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Multifocal Motor Neuropathy
  • Age: 18 years - 99 years
  • Gender: All
Updated on 04 Aug 2024. Study ID: 850467

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center